John P. Morris - Concepedia

Author

John P. Morris

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Chen, Chun-Wei, J Morris, J. Morris, J.P. Morris, John Morris, John Morris IV, John P Morris, John P. Morris, John P. Morris IV, John P. Morris

123

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Howard Hughes Medical Institute University of California, San Francisco Cornell University Harvard University

About

John P. Morris is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	22	7.6K
2	Public Health	2	2	62
3	Health Sciences	1	1	78
4	Natural Sciences	1	1	295
5	Anatomy	1	1	72

John P. Morris

Publications

9.4K

Citations

H-Index

Page 1

	Year	Citations
Activating Mutations of <i>NOTCH1</i> in Human T Cell Acute Lymphoblastic Leukemia Andrew P. Weng, Adolfo A. Ferrando, Woojoong Lee, Science Hematological MalignancyHuman T-allActivated Notch1Lymphocyte DevelopmentHuman T Cell	2004	2.7K
Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma Janel L. Kopp, Guido von Figura, Erin Mayes, Cancer Cell Signal TransductionPancreatic CancerPathologySox9-dependent Acinar-to-ductal ReprogrammingPancreatic Surgery	2012	679
<i>tp53</i> mutant zebrafish develop malignant peripheral nerve sheath tumors Stéphane Berghmans, Ryan D. Murphey, Erno Wienholds, Proceedings of the National Academy of Sciences	2005	611
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression Akihisa Fukuda, Sam C. Wang, John P. Morris, Cancer Cell Tumor BiologyPancreatic CancerMedicineMmp7 ContributePathology	2011	518
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling Susann Weissmueller, Eusebio Manchado, Michael Saborowski, Cell Tumor BiologyPancreatic CancerMedicineCancer Cell BiologyTumor Suppressor	2014	469
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression Sung‐Hwan Moon, Chun‐Hao Huang, Shauna L Houlihan, Cell MedicineMevalonate PathwayTumor SuppressorCancer BiologyCell Biology	2018	442
A combinatorial strategy for treating KRAS-mutant lung cancer Eusebio Manchado, Susann Weissmueller, John P. Morris, Nature MedicineBronchial NeoplasmKras-mutant Lung CancerCancer TreatmentSystems Biology	2016	397
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, Cell Pancreatic CancerPancreas CancerCellular SenescenceMedicineCell Biology	2020	392
β-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice John P. Morris, David A. Cano, Shigeki Sekine, Journal of Clinical Investigation Cancer BiologyCellular PlasticityTumor BiologyTissue DevelopmentSignaling Pathway	2010	364
A gene–environment-induced epigenetic program initiates tumorigenesis Direna Alonso‐Curbelo, Yu-Jui Ho, Cassandra Burdziak, Nature ChromatinChromatin StructureMedicineNatural SciencesMolecular Epigenetics	2021	295

Page 1